Idiopahtic pulmonary fibrosis research hub

A randomised, open-label, 5-period, cross-over trial to assess the pharmacokinetics and safety of 3 oral solid formulations of buloxibutid (C21) in healthy male and female participants

This study is testing new forms of a medicine called buloxibutid in healthy people. We want to see how the body handles the medicine and if it's safe. It's for a lung condition called Idiopathic Pulmonary Fibrosis.